Literature DB >> 11839563

Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma.

Eva Röijer1, Anders Nordkvist, Anna-Karin Ström, Walter Ryd, Margareta Behrendt, Jörn Bullerdiek, Joachim Mark, Göran Stenman.   

Abstract

Carcinoma ex pleomorphic adenoma (CexPA) is a carcinoma developing within a pre-existing benign pleomorphic adenoma (PA). Here we describe the identification and characterization of a series of genetic events leading to translocation, deletion/amplification, and overexpression of the HMGIC and MDM2 genes in a CexPA at an early stage of development. The tumor had a pseudodiploid stemline karyotype with a del(5)(q22-23q32-33) and a t(10;12)(p15;q14-15). In addition, there were several sidelines with double minute chromosomes (dmin) or homogeneously staining regions (hsr). Fluorescence in situ hybridization (FISH) mapping revealed that the 12q14-15 breakpoint was located centromeric to HMGIC and that the entire gene was juxtaposed to the der(10) chromosome. Detailed analysis of cells with dmin and hsr revealed that HMGIC and MDM2 were deleted from the der(10) and that the dmin and hsr were strongly positive for both genes. Southern blot analysis confirmed that both HMGIC and MDM2 were amplified and that no gross rearrangements of the genes had occurred. Immunostaining revealed that the HMGIC protein was highly overexpressed particularly in the large polymorphic cells within the carcinomatous part of the tumor. These findings suggest that amplification and overexpression of HMGIC and possibly MDM2 might be important genetic events that may contribute to malignant transformation of benign PA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839563      PMCID: PMC1850659          DOI: 10.1016/S0002-9440(10)64862-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.

Authors:  J M Berner; L A Meza-Zepeda; P F Kools; A Forus; E F Schoenmakers; W J Van de Ven; O Fodstad; O Myklebost
Journal:  Oncogene       Date:  1997-06-19       Impact factor: 9.867

2.  Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland.

Authors:  P H Rao; V V Murty; D C Louie; R S Chaganti
Journal:  Cancer Genet Cytogenet       Date:  1998-09

3.  Fluorescence in situ hybridization mapping of breakpoints in pleomorphic adenomas with 8q12-13 abnormalities identifies a subgroup of tumors without PLAG1 involvement.

Authors:  E Röijer; K Kas; M Behrendt; W Van de Ven; G Stenman
Journal:  Genes Chromosomes Cancer       Date:  1999-01       Impact factor: 5.006

4.  Allelic knockout of novel splice variants of human recombination repair gene RAD51B in t(12;14) uterine leiomyomas.

Authors:  E F Schoenmakers; C Huysmans; W J Van de Ven
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

5.  Impact of the in vitro technique used on the cytogenetic patterns in pleomorphic adenomas.

Authors:  J Mark; R Dahlenfors; B Wedell
Journal:  Cancer Genet Cytogenet       Date:  1997-05

6.  Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas.

Authors:  J M Geurts; E F Schoenmakers; E Röijer; A K Aström; G Stenman; W J van de Ven
Journal:  Oncogene       Date:  1998-02-19       Impact factor: 9.867

7.  Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.

Authors:  G Reifenberger; K Ichimura; J Reifenberger; A G Elkahloun; P S Meltzer; V P Collins
Journal:  Cancer Res       Date:  1996-11-15       Impact factor: 12.701

8.  Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12).

Authors:  E Röijer; K Kas; I Klawitz; J Bullerdiek; W Van de Ven; G Stenman
Journal:  Genes Chromosomes Cancer       Date:  1996-11       Impact factor: 5.006

9.  Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.

Authors:  A K Aström; M L Voz; K Kas; E Röijer; B Wedell; N Mandahl; W Van de Ven; J Mark; G Stenman
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

10.  The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter.

Authors:  M L Voz; A K Aström; K Kas; J Mark; G Stenman; W J Van de Ven
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

View more
  21 in total

Review 1.  Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data.

Authors:  Joyce Antony; Vinod Gopalan; Robert A Smith; Alfred K Y Lam
Journal:  Head Neck Pathol       Date:  2011-07-09

2.  Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy.

Authors:  N Chooback; Y Shen; M Jones; K Kasaian; M Martin; T Ng; T Thomson; M Marra; J Laskin; C Ho
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

3.  PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.

Authors:  Armita Bahrami; James D Dalton; Bangalore Shivakumar; Jeffrey F Krane
Journal:  Head Neck Pathol       Date:  2012-04-08

Review 4.  Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.

Authors:  Franck Toledo; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

5.  Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure.

Authors:  Clelia Tiziana Storlazzi; Angelo Lonoce; Maria C Guastadisegni; Domenico Trombetta; Pietro D'Addabbo; Giulia Daniele; Alberto L'Abbate; Gemma Macchia; Cecilia Surace; Klaas Kok; Reinhard Ullmann; Stefania Purgato; Orazio Palumbo; Massimo Carella; Peter F Ambros; Mariano Rocchi
Journal:  Genome Res       Date:  2010-07-14       Impact factor: 9.043

6.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

7.  [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].

Authors:  A Fehr; G Stenman; J Bullerdiek; T Löning
Journal:  Pathologe       Date:  2009-11       Impact factor: 1.011

Review 8.  Giant deep lobe parotid gland pleomorphic adenoma involving the parapharyngeal space. Report of three cases and review of the diagnostic and therapeutic approaches.

Authors:  B Sergi; A Limongelli; E Scarano; A R Fetoni; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-10       Impact factor: 2.124

9.  Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance.

Authors:  Shin-Ichiro Maruya; Hyung-Woo Kim; Randal S Weber; Jack J Lee; Merril Kies; Mario A Luna; John G Batsakis; Adel K El-Naggar
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

10.  Establishment and characterization of pleomorphic adenoma cell systems: an in-vitro demonstration of carcinomas arising secondarily from adenomas in the salivary gland.

Authors:  Satoshi Maruyama; Jun Cheng; Susumu Shingaki; Takashi Tamura; Shuichi Asakawa; Shinsei Minoshima; Yoshiko Shimizu; Nobuyoshi Shimizu; Takashi Saku
Journal:  BMC Cancer       Date:  2009-07-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.